Published in JAMA on March 15, 2006
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ (2009) 22.18
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. PLoS Med (2009) 21.74
The role of vitamin D and calcium in type 2 diabetes. A systematic review and meta-analysis. J Clin Endocrinol Metab (2007) 8.91
CONSORT for reporting randomized controlled trials in journal and conference abstracts: explanation and elaboration. PLoS Med (2008) 5.85
Non-publication of large randomized clinical trials: cross sectional analysis. BMJ (2013) 4.91
From abstract to impact in cardiovascular research: factors predicting publication and citation. Eur Heart J (2012) 1.79
Long-term antidepressant treatment in bipolar disorder: meta-analyses of benefits and risks. Acta Psychiatr Scand (2008) 1.78
The Canadian Hypertension Education Program--a unique Canadian initiative. Can J Cardiol (2006) 1.76
Quality of pharmaceutical industry press releases based on original research. PLoS One (2008) 1.07
Authors report lack of time as main reason for unpublished research presented at biomedical conferences: a systematic review. J Clin Epidemiol (2015) 1.00
A systematic review of clinical trials of pharmacological interventions for acute ischaemic stroke (1955-2008) that were completed, but not published in full. Trials (2010) 0.98
Does direction of results of abstracts submitted to scientific conferences on drug addiction predict full publication? BMC Med Res Methodol (2009) 0.85
Gabapentin versus tricyclic antidepressants for diabetic neuropathy and post-herpetic neuralgia: discrepancies between direct and indirect meta-analyses of randomized controlled trials. J Gen Intern Med (2008) 0.85
ClinicalTrials.gov registration can supplement information in abstracts for systematic reviews: a comparison study. BMC Med Res Methodol (2013) 0.84
Full-text publication of abstract-presented work in physical therapy: do therapists publish what they preach? Phys Ther (2010) 0.83
The prevention, detection and management of cancer treatment-induced cardiotoxicity: a meta-review. BMC Cancer (2015) 0.82
The fate of conference abstracts: systematic review and meta-analysis of surgical treatments for men with benign prostatic enlargement. World J Urol (2010) 0.81
How transparent are migraine clinical trials? Repository of Registered Migraine Trials (RReMiT). Neurology (2014) 0.81
Publication patterns of cancer cost-effectiveness studies presented at major conferences. Curr Oncol (2013) 0.81
PCSK9 antibodies for the treatment of hypercholesterolemia. Nutrients (2014) 0.80
Pathways through opiate use and offending: A systematic review. Int J Drug Policy (2016) 0.79
Using ClinicalTrials.gov to supplement information in ophthalmology conference abstracts about trial outcomes: a comparison study. PLoS One (2015) 0.77
Systematic Review and Meta-Analysis of Tacrolimus versus Ciclosporin as Primary Immunosuppression After Liver Transplant. PLoS One (2016) 0.76
Assessing the detection, reporting and investigation of adverse events in clinical trial protocols implemented in Cameroon: a documentary review of clinical trial protocols. BMC Med Ethics (2015) 0.75
Comparison of meeting abstracts and subsequent articles. JAMA (2006) 0.75
Archiving "event knowledge": bringing "dark data" to light. J Med Libr Assoc (2008) 0.75
Analysis of full-text publication and publishing predictors of abstracts presented at an Italian public health meeting (2005-2007). BMC Res Notes (2015) 0.75
Impact of high dose statin trials on hospital prescribers. Eur J Clin Pharmacol (2006) 0.75
Search for unpublished data by systematic reviewers: an audit. BMJ Open (2017) 0.75
Universal definition of myocardial infarction. Circulation (2007) 11.69
Effect of Sitagliptin on Cardiovascular Outcomes in Type 2 Diabetes. N Engl J Med (2015) 9.70
Third universal definition of myocardial infarction. J Am Coll Cardiol (2012) 8.59
Third universal definition of myocardial infarction. Circulation (2012) 8.47
Third universal definition of myocardial infarction. Eur Heart J (2012) 7.98
Structured telephone support or telemonitoring programmes for patients with chronic heart failure. Cochrane Database Syst Rev (2010) 6.49
Relationship of blood transfusion and clinical outcomes in patients with acute coronary syndromes. JAMA (2004) 5.11
Platelet glycoprotein IIb/IIIa inhibitors in acute coronary syndromes: a meta-analysis of all major randomised clinical trials. Lancet (2002) 5.04
Re-examining the efficacy of beta-blockers for the treatment of hypertension: a meta-analysis. CMAJ (2006) 5.03
Telemonitoring or structured telephone support programmes for patients with chronic heart failure: systematic review and meta-analysis. BMJ (2007) 5.02
Acetylcysteine in the prevention of contrast-induced nephropathy: a case study of the pitfalls in the evolution of evidence. Arch Intern Med (2006) 4.90
Contemporary management of chronic obstructive pulmonary disease: scientific review. JAMA (2003) 4.88
Meta-analysis: secondary prevention programs for patients with coronary artery disease. Ann Intern Med (2005) 4.85
Improved clinical outcomes associated with metformin in patients with diabetes and heart failure. Diabetes Care (2005) 4.78
Effect of calcium-based versus non-calcium-based phosphate binders on mortality in patients with chronic kidney disease: an updated systematic review and meta-analysis. Lancet (2013) 4.58
Prasugrel versus clopidogrel for acute coronary syndromes without revascularization. N Engl J Med (2012) 4.49
Anemia is common in heart failure and is associated with poor outcomes: insights from a cohort of 12 065 patients with new-onset heart failure. Circulation (2003) 4.43
Benefits and harms of antidiabetic agents in patients with diabetes and heart failure: systematic review. BMJ (2007) 3.95
New evidence for stroke prevention: scientific review. JAMA (2002) 3.70
2007 focused update of the ACC/AHA 2004 guidelines for the management of patients with ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol (2008) 3.70
Prognostic value of growth-differentiation factor-15 in patients with non-ST-elevation acute coronary syndrome. Circulation (2007) 3.62
Statins and outcomes in patients admitted to hospital with community acquired pneumonia: population based prospective cohort study. BMJ (2006) 3.62
Agreement among cardiovascular disease risk calculators. Circulation (2013) 3.58
Accuracy of administrative databases in identifying patients with hypertension. Open Med (2007) 3.56
Renal insufficiency and heart failure: prognostic and therapeutic implications from a prospective cohort study. Circulation (2004) 3.56
Implantable cardioverter defibrillators in primary and secondary prevention: a systematic review of randomized, controlled trials. Ann Intern Med (2003) 3.43
Body mass index and mortality in heart failure: a meta-analysis. Am Heart J (2008) 3.25
A randomized trial of the effect of community pharmacist and nurse care on improving blood pressure management in patients with diabetes mellitus: study of cardiovascular risk intervention by pharmacists-hypertension (SCRIP-HTN). Arch Intern Med (2008) 3.21
Thrombin-receptor antagonist vorapaxar in acute coronary syndromes. N Engl J Med (2011) 3.20
Randomized trial of warfarin, aspirin, and clopidogrel in patients with chronic heart failure: the Warfarin and Antiplatelet Therapy in Chronic Heart Failure (WATCH) trial. Circulation (2009) 3.18
A meta-analysis of the effect of exercise training on left ventricular remodeling in heart failure patients: the benefit depends on the type of training performed. J Am Coll Cardiol (2007) 3.16
Prognostic significance of the change in glucose level in the first 24 h after acute myocardial infarction: results from the CARDINAL study. Eur Heart J (2006) 3.14
Steroids and bronchodilators for acute bronchiolitis in the first two years of life: systematic review and meta-analysis. BMJ (2011) 3.00
Cardiac resynchronization therapy for patients with left ventricular systolic dysfunction: a systematic review. JAMA (2007) 2.93
Darapladib for preventing ischemic events in stable coronary heart disease. N Engl J Med (2014) 2.90
A randomized trial of nebulized 3% hypertonic saline with epinephrine in the treatment of acute bronchiolitis in the emergency department. Arch Pediatr Adolesc Med (2009) 2.89
Declining in-hospital mortality and increasing heart failure incidence in elderly patients with first myocardial infarction. J Am Coll Cardiol (2009) 2.82
International variation in and factors associated with hospital readmission after myocardial infarction. JAMA (2012) 2.75
Validation of a case definition to define hypertension using administrative data. Hypertension (2009) 2.74
Preoperative hypernatremia predicts increased perioperative morbidity and mortality. Am J Med (2013) 2.69
Consensus Statement on Diagnostic Criteria for PHACE Syndrome. Pediatrics (2009) 2.58
Evidence of suboptimal management of cardiovascular risk in patients with type 2 diabetes mellitus and symptomatic atherosclerosis. CMAJ (2004) 2.55
Pharmacist care of patients with heart failure: a systematic review of randomized trials. Arch Intern Med (2008) 2.55
Impact of specialist follow-up in outpatients with congestive heart failure. CMAJ (2005) 2.50
Early versus delayed, provisional eptifibatide in acute coronary syndromes. N Engl J Med (2009) 2.49
International differences in evolution of early discharge after acute myocardial infarction. Lancet (2004) 2.47
Preoperative hyponatremia and perioperative complications. Arch Intern Med (2012) 2.42
Efficacy of statins for primary prevention in people at low cardiovascular risk: a meta-analysis. CMAJ (2011) 2.40
Aldosterone blockade and left ventricular dysfunction: a systematic review of randomized clinical trials. Eur Heart J (2008) 2.37
Does performance-based remuneration for individual health care practitioners affect patient care?: a systematic review. Ann Intern Med (2012) 2.35
Meta-analysis: cardiac resynchronization therapy for patients with less symptomatic heart failure. Ann Intern Med (2011) 2.34
The association among renal insufficiency, pharmacotherapy, and outcomes in 6,427 patients with heart failure and coronary artery disease. J Am Coll Cardiol (2004) 2.32
Mortality and readmission of patients with heart failure, atrial fibrillation, or coronary artery disease undergoing noncardiac surgery: an analysis of 38 047 patients. Circulation (2011) 2.30
Meditation practices for health: state of the research. Evid Rep Technol Assess (Full Rep) (2007) 2.27
Aborted myocardial infarction: a new target for reperfusion therapy. Eur Heart J (2006) 2.26
The effects of inhaled corticosteroids in chronic obstructive pulmonary disease: a systematic review of randomized placebo-controlled trials. Am J Med (2002) 2.26
Single data extraction generated more errors than double data extraction in systematic reviews. J Clin Epidemiol (2006) 2.23
Increases in antihypertensive prescriptions and reductions in cardiovascular events in Canada. Hypertension (2008) 2.23
Stroke: strategies for primary prevention. Am Fam Physician (2003) 2.19
ST-segment recovery and outcome after primary percutaneous coronary intervention for ST-elevation myocardial infarction: insights from the Assessment of Pexelizumab in Acute Myocardial Infarction (APEX-AMI) trial. Circulation (2008) 2.19
Sex differences in mortality following acute coronary syndromes. JAMA (2009) 2.17
The efficacy and safety of drug treatments for chronic insomnia in adults: a meta-analysis of RCTs. J Gen Intern Med (2007) 2.16
From knowledge to practice in chronic cardiovascular disease: a long and winding road. J Am Coll Cardiol (2004) 2.16
The impact of the Canadian Hypertension Education Program on antihypertensive prescribing trends. Hypertension (2005) 2.15
Efficacy and safety of exogenous melatonin for secondary sleep disorders and sleep disorders accompanying sleep restriction: meta-analysis. BMJ (2006) 2.09
The failure of orally administered glycoprotein IIb/IIIa inhibitors to prevent recurrent cardiac events. Am J Med (2002) 2.09
Aspirin use and outcomes in a community-based cohort of 7352 patients discharged after first hospitalization for heart failure. Circulation (2006) 2.05
The 2005 Canadian Hypertension Education Program recommendations for the management of hypertension: part II - therapy. Can J Cardiol (2005) 2.03
Cardiovascular outcomes in framingham participants with diabetes: the importance of blood pressure. Hypertension (2011) 2.02
A systematic review of drug therapy to delay or prevent type 2 diabetes. Diabetes Care (2005) 2.01
The 2007 Canadian Hypertension Education Program recommendations for the management of hypertension: part 2 - therapy. Can J Cardiol (2007) 2.01
Heart failure is a risk factor for orthopedic fracture: a population-based analysis of 16,294 patients. Circulation (2008) 1.98
Incidence, treatment, and outcomes of atrial fibrillation complicating non-ST-segment elevation acute coronary syndromes. Int J Cardiol (2013) 1.95
A systematic review identifies a lack of standardization in methods for handling missing variance data. J Clin Epidemiol (2006) 1.95
Antipsychotics for children and young adults: a comparative effectiveness review. Pediatrics (2012) 1.93
Blood pressure in Canadian adults. Health Rep (2010) 1.93
Incidence of and outcomes associated with ventricular tachycardia or fibrillation in patients undergoing primary percutaneous coronary intervention. JAMA (2009) 1.80
Better outcomes for patients treated at hospitals that participate in clinical trials. Arch Intern Med (2008) 1.77
Glucocorticoids for acute viral bronchiolitis in infants and young children. Cochrane Database Syst Rev (2013) 1.77
Clinical features suggestive of meningitis in children: a systematic review of prospective data. Pediatrics (2010) 1.76
Temporal trends in antihypertensive drug prescriptions in Canada before and after introduction of the Canadian Hypertension Education Program. J Hypertens (2003) 1.76
Benefits and harms of treating gestational diabetes mellitus: a systematic review and meta-analysis for the U.S. Preventive Services Task Force and the National Institutes of Health Office of Medical Applications of Research. Ann Intern Med (2013) 1.74